Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle

被引:223
|
作者
Wojtaszewski, JFP
Jorgensen, SB
Hellsten, Y
Hardie, DG
Richter, EA
机构
[1] Univ Copenhagen, Copenhagen Muscle Res Ctr, Inst Exercise & Sports Sci, DK-2100 Copenhagen, Denmark
[2] Univ Dundee, Sch Life Sci, Div Mol Physiol, Dundee, Scotland
关键词
D O I
10.2337/diabetes.51.2.284
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5'-AMP-activated protein kinase (AMPK) functions as a metabolic switch in mammalian cells and can be artificially activated by 5-aminoimidazole-4-caxboxamide (AICA)-riboside. AMPK activation during muscle contraction is dependent on muscle glycogen concentrations, but whether glycogen also modifies the activation of AMPK and its possible downstream effectors (glycogen synthase and glucose transport) by AICA-riboside in resting muscle is not known. Thus, we have altered muscle glycogen levels in rats by a combination of swimming exercise and diet and investigated the effects of AICA-riboside in the perfused rat hindlimb muscle. Two groups of rats, one with super-compensated muscle glycogen content (similar to200-300% of normal; high glycogen [HG]) and one with moderately lowered muscle glycogen content (similar to80% of normal; low glycogen [LG]), were generated. In both groups, the degree of activation of the alpha2 isoform of AMPK by AICA-riboside depended on muscle type (white gastrocnemius much greater than red gastrocnemius > soleus). Basal and AICA-riboside-induced alpha2-AMPK activity were markedly lowered in the HG group (similar to50%) compared with the LG group. Muscle 2-deoxyglucose uptake was also increased and glycogen synthase activity decreased by AICA-riboside. Especially in white gastrocnemius, these effects, as well as the absolute activity levels of AMPK-alpha2, were markedly reduced in the HG group compared with the LG group. The inactivation of glycogen synthase by AICA-riboside was accompanied by decreased gel mobility and was eliminated by protein phosphatase treatment. We conclude that acute AICA-riboside treatment leads to phosphorylation and deactivation of glycogen synthase in skeletal muscle. Although the data do not exclude a role of other kinases/phosphatases, they suggest that glycogen synthase may be a target for AMPK in vivo. Both basal and AICA-riboside-induced AMPK-alpha2 and glycogen synthase activities, as well as glucose transport, are depressed when the glycogen stores are plentiful. Because the glycogen level did not affect adenine nucleotide concentrations, our data suggest that glycogen may directly affect the activation state of AMPK in skeletal muscle.
引用
收藏
页码:284 / 292
页数:9
相关论文
共 50 条
  • [21] Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation
    Barre, Laura
    Richardson, Christine
    Hirshman, Michael F.
    Brozinick, Joseph
    Fiering, Steven
    Kemp, Bruce E.
    Goodyear, Laurie J.
    Witters, Lee A.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (03): : E802 - E811
  • [22] Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle
    Holmes, BF
    Kurth-Kraczek, EJ
    Winder, WW
    JOURNAL OF APPLIED PHYSIOLOGY, 1999, 87 (05) : 1990 - 1995
  • [23] The regulation of ceramide content by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) in rat skeletal muscle
    Choi, MD
    Olesen, JB
    Pattison, SE
    Vann, CN
    Kang, HY
    Craig, BW
    FASEB JOURNAL, 2006, 20 (04): : A166 - A166
  • [24] Role of 5′AMP-activated protein kinase in skeletal muscle
    Treebak, J. T.
    Wojtaszewski, J. F. P.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (Suppl 4) : S13 - S17
  • [25] Role of 5′AMP-activated protein kinase in skeletal muscle
    J T Treebak
    J F P Wojtaszewski
    International Journal of Obesity, 2008, 32 : S13 - S17
  • [26] Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside -: Evidence for involvement of AMP-activated protein kinase
    Samari, HR
    Seglen, PO
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 23758 - 23763
  • [27] Regulation of myocardial glycogen turnover by 5'-AMP-activated protein kinase (AMPK)
    Fraser, H
    Lopaschuk, GD
    Clanachan, AS
    CIRCULATION, 1997, 96 (08) : 3202 - 3202
  • [28] Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
    Saha, AK
    Schwarsin, AJ
    Roduit, R
    Massé, F
    Kaushik, V
    Tornheim, K
    Prentki, M
    Ruderman, NB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) : 24279 - 24283
  • [29] AMP-activated protein kinase does not associate with glycogen α-particles from rat liver
    Parker, Glendon J.
    Koay, Ann
    Gilbert-Wilson, Ryan
    Waddington, Lynne J.
    Stapleton, David
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (04) : 811 - 815
  • [30] EXPANSION OF CARDIAC AND SKELETAL-MUSCLE NUCLEOTIDE POOLS BY INFUSION OF THE NUCLEOTIDE PRECURSOR 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE (AICAR)
    SABINA, RL
    KERNSTINE, K
    HOLMES, EW
    SWAIN, JL
    CIRCULATION, 1981, 64 (04) : 275 - 275